4/A

FORM 4/A SUBMISSION

Company: Oncotelic Therapeutics, Inc.
Filed: April 19, 2016
Period of Report: March 21, 2016
Accession Number: 0001209191-16-114834

View Document ↗ View on SEC.gov ↗